Long COVID headache

C Tana, E Bentivegna, SJ Cho, AM Harriott… - The journal of headache …, 2022 - Springer
Headache is among the most frequent symptoms persisting or newly developing after
coronavirus disease 2019 (COVID-19) as part of the so-called long COVID syndrome. The …

[HTML][HTML] Smoking and risk of negative outcomes among COVID-19 patients: a systematic review and meta-analysis

A Umnuaypornlert, S Kanchanasurakit… - Tobacco induced …, 2021 - ncbi.nlm.nih.gov
METHODS Electronic databases, including PubMed, EMBASE, Cochrane Library, Science
Direct, Google Scholar, were systematically searched from the initiation of the database until …

Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19

M Bellan, A Baricich, F Patrucco, P Zeppegno… - Scientific reports, 2021 - nature.com
Abstract Many coronavirus disease 2019 (Covid-19) survivors show symptoms months after
acute illness. The aim of this work is to describe the clinical evolution of Covid-19, one year …

Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis

JS Geng, XL Yu, HN Bao, Z Feng, XY Yuan… - Frontiers in …, 2021 - frontiersin.org
Introduction: Given the ongoing coronavirus disease 2019 (COVID-19) pandemic and the
consequent global healthcare crisis, there is an urgent need to better understand risk factors …

Blood interferon-α levels and severity, outcomes, and inflammatory profiles in hospitalized COVID-19 patients

M Contoli, A Papi, L Tomassetti, P Rizzo… - Frontiers in …, 2021 - frontiersin.org
Background: Deficient interferon responses have been proposed as one of the relevant
mechanisms prompting severe manifestations of COVID-19. Objective: To evaluate the …

Risk factors for hospitalization among persons with COVID-19—Colorado

GM Vahey, E McDonald, K Marshall, SW Martin… - PloS one, 2021 - journals.plos.org
Background Most current evidence on risk factors for hospitalization because of coronavirus
disease 2019 (COVID-19) comes from studies using data abstracted primarily from …

Efficacy of losartan in hospitalized patients with COVID-19–induced lung injury: a randomized clinical trial

MA Puskarich, NE Ingraham, LH Merck… - JAMA network …, 2022 - jamanetwork.com
Importance SARS-CoV-2 viral entry may disrupt angiotensin II (AII) homeostasis,
contributing to COVID-19 induced lung injury. AII type 1 receptor blockade mitigates lung …

A serum proteome signature to predict mortality in severe COVID-19 patients

F Völlmy, H Van Den Toorn, RZ Chiozzi… - Life Science …, 2021 - life-science-alliance.org
Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to
respiratory and intensive care units because of respiratory failure. We received, for most …

Health equity, care access and quality in headache–part 1

C Tana, B Raffaelli, MNP Souza, ER de la Torre… - The Journal of …, 2024 - Springer
Current definitions of migraine that are based mainly on clinical characteristics do not
account for other patient's features such as those related to an impaired quality of life, due to …

A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity

J Xu, W Xiao, X Liang, L Shi, P Zhang, Y Wang… - BMC public health, 2021 - Springer
Background Cardiovascular disease (CVD), one of the most common comorbidities of
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …